Transformers & Rectifiers reported a 37 per cent jump in consolidated profit after tax (PAT) for the December quarter to ₹76 ...
Transformer & Rectifiers (India) (TARIL) declined 9.15% to Rs 291.85 after the company's chief executive officer (CEO), Mukul Srivastava resigned with effect from close of business hours on 7 January, ...
The Indian stock market faced another decline on January 9, with Nifty 50 falling 0.75% and Sensex down 0.72%. The week saw ...
Mwale, L. and Nhlapo, B. (2026) High Voltage Direct Current (HVDC) Transmission Technology and DC Grids a Comprehensive ...
Guitar World on MSN
Stray Kids guitarist Garrett Jones on his journey from suburban Detroit to K-pop session pro
Using a range of classic instruments and an analog-digital hybrid rig, he learned so much with boy band Stray Kids that he ...
Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Enphase Energy started shipping its IQ9N-3P Commercial Microinverter across the United States in late December 2025. The ...
Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...
Indian equities closed higher Monday, with the Sensex and Nifty snapping a five-session losing streak after a late-afternoon ...
3don MSN
Stocks to buy under ₹100: Sumeet Bagadia recommends three stocks to buy on Monday - 12 January 2025
Sumeet Bagadia has recommended three stocks to buy on Monday, January 12. The three stock picks by Bagadia are - Ujjivan ...
NDTV Profit on MSN
Stock Picks Today: Divi’s Labs, Apollo Hospitals, IDFC First Bank And More On Brokerages’ Radar
They have also shared their outlook on pharmaceuticals, telecom, healthcare, metals and banking, alongside broader commentary on India’s growth outlook, GDP trajectory and the evolving earnings cycle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results